Apolipoprotein(a) stimulates nuclear translocation of βcatenin: A novel pathogenic mechanism for lipoprotein(a)

Molecular Biology of the Cell

Volumn 24, Issue 3, 2013, Pages 210-221

  Cho, Taewoo ^a   Romagnuolo, Rocco ^b   Scipione, Corey ^b   Boffa, Michael B ^b   Koschinsky, Marlys L ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WINDSOR   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; BETA CATENIN; CYCLOOXYGENASE 2; GLYCOGEN SYNTHASE KINASE 3BETA; LYSINE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROSTAGLANDIN E2; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; PROTEIN VARIANT; RECOMBINANT PROTEIN; TENSIN; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; ATHEROGENESIS; CELL FUNCTION; CELL NUCLEUS; CHROMOSOME 10; CONTROLLED STUDY; DISSOCIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; MUTANT; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIGENS, CD; APOPROTEIN(A); ATHEROSCLEROSIS; BETA CATENIN; BINDING SITES; CADHERINS; CELL NUCLEUS; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INDUCTION; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; PHOSPHATIDYLINOSITOL 3-KINASES; PLASMINOGEN; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN TRANSPORT; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84873354653     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-08-0637     Document Type: Article

References (50)

1. Angelini DJ, Hyun SW, Grigoryev DN, Garg P, Gong P, Singh IS, Passaniti A, Hasday JD, Goldblum SE (2006). TNFalpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol 291, L1232-L1245.
2. Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M, Miura K, Harris CC (2003). Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res 63, 728-734.
3. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG (2000). Toll-like receptor 2-mediated NFκB activation requires a Rac1-dependent pathway. Nat Immunol 1, 533-540.
4. Barbieri SS, Ruggiero L, Tremoli E, Weksler BB (2008). Suppressing PTEN activity by tobacco smoke plus interleukin-1β modulates dissociation of VE-cadherin/β-catenin complexes in endothelium. Arterioscler Thromb Vasc Biol 28, 732-738.
5. Barbieri SS, Weksler BB (2007). Tobacco smoke cooperates with interleukin-1β to alter β-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo. FASEB J 21, 1831-1842.
6. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W (1998). Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 280, 596-599.
7. Cho T, Jung Y, Koschinsky ML (2008). Apolipoprotein(a), through its strong lysine-binding site in KIV10, mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway. J Biol Chem 283, 30503-30512.
8. Coffer PJ, Jin J, Woodgett JR (1998). Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335, 1-12.
9. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
10. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN (2005). Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol 23, 254-266.
11. Dejana E, Orsenigo F, Lampugnani MG (2008). The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121, 2115-2122.
12. Donella-Deana A et al. (2003). Tyrosine phosphorylation of protein kinase CK2 by Src-related tyrosine kinases correlates with increased catalytic activity. Biochem J 372, 841-849.
13. Downward J (1998). Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10, 262-267.
14. Dubé JB, Boffa MB, Hegele RA, Koschinsky M (2012). Lipoprotein(a): more interesting than ever after 50 years. Curr Opin Lipidol 23, 133-140.
15. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W (1998). Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111, 1853-1865.
16. Essler M, Retzer M, Bauer M, Heemsker JW, Aepfelbacher M, Seiss W (1999). Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase. J Biol Chem 274, 30361-30364.
17. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998). Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512.
18. Hemmings BA (1997). PtdIns(3,4,5)P3 gets its message across. Science 275, 628-630.
19. Hildesheim J, Salvador JM, Hollander MC, Fornace AJ Jr. (2005). Casein kinase 2-and protein kinase A-regulated adenomatous polyposis coli and β-catenin cellular localization is dependent on p38 MAPK. J Biol Chem 280, 17221-17226
20. Hughes SD, Lou XJ, Ighani S, Verstuyft J, Grainger DJ, Lawn RM, Rubin EM (1997). Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus. J Clin Invest 100, 1493-1500.
21. Janssens S, Beyaert R (2002). A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem Sci 27, 474-482.
22. Kim SJ, Im DS, Kim SH, Ryu JH, Hwang SG, Seong JK, Chun CH, Chun JS (2002). Beta-catenin regulates expression of cyclooxygenase-2 in articular chondrocytes. Biochem Biophys Res Commun 296, 221-226.
23. Koschinsky ML, Côté GP, Gabel B, van der Hoek YY (1993). Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J Biol Chem 268, 19819-19825.
24. Koschinsky ML, Marcovina SM (2009). Lipoprotein(a). In: Clinical Lipidology: A Companion to Braunwald's Heart Disease, ed. CM Ballantyne, Philadelphia: Saunders (Elsevier), 130-142.
25. Koschinsky ML, Tomlinson ZE, Zioncheck TF, Schwartz K, Eaton DL, Lawn RM (1991). Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry 30, 5044-5051.
26. Kotelevets L, van Hengel J, Bruyneel E, Mareel M, van Roy F, Chastre E (2005). Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J 19, 115-117.
27. Krysan K, Lee JM, Dohadwala M, Gardner BK, Reckamp KL, Garon E, St John M, Sharma S, Dubinett SM (2008). Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance. J Thorac Oncol 3, 107-110.
28. Maehama T, Dixon JE (1998). The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273, 13375-13378.
29. Maehama T, Taylor GS, Dixon JE (2001). PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem 70, 247-279.
30. Manukyan M, Nalbant P, Luxen S, Hahn KM, Knaus UG (2009). RhoA GTPase activation by TLR2 and TLR3 ligands: connecting via Src to NFκB. J Immunol 182, 3522-3529.
31. McLean JW, Tomlinson JE, Kuang WH, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM (1987). cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330, 132-137.
32. O'Neil CH, Boffa MB, Hancock MA, Pickering JG, Koschinsky ML (2004). Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-β activation and on the presence of kringle IV type 9. J Biol Chem 279, 55187-55195.
33. Ozawa M, Baribault H, Kemler R (1989). The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8, 1711-1717.
34. Pellegrino M, Furmaniak-Kazmierczak E, LeBlanc JC, Cho T, Cao K, Marcovina SM, Boffa MB, Côté GP, Koschinsky ML (2004). The apolipoprotein(a) component of lipoprotein(a) stimulates actin stress fiber formation and loss of cell-cell contact in cultured endothelial cells. J Biol Chem 279, 6526-6532.
35. Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T (2007). Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol 27, 1312-1318.
36. Sangrar W, Gabel BR, Boffa MB, Walker JB, Hancock MA, Marcovina SM, Horrevoets AJ, Nesheim ME, Koschinsky ML (1997). The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface. Biochemistry 36, 10353-10362.
37. Sangrar W, Koschinsky ML (2000). Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots. Biochem Cell Biol 78, 519-525.
38. Seimon TA et al. (2010). Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12, 467-482.
39. Shasby DM, Ries DR, Shasby SS, Winter MC (2002). Histamine stimulates phosphorylation of adherens junction proteins and alters their link to vimentin. Am J Physiol Lung Cell Mol Physiol 282, L1330-L1338.
40. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A (1999). The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96, 5522-5527.
41. Sotiriou SN et al. (2006). Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. FASEB J 20, 559-561.
42. Stemme V, Swedenborg J, Claesson H, Hansson GK (2000). Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg 20, 146-152.
43. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H (1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96, 6199-204.
44. Tam SP, Zhang X, Koschinsky ML (1996). Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2. J Lipid Res 37, 518-532.
45. Tsimikas S, Hall JL (2012). Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease. J Am Coll Cardiol 60, 716-721.
46. Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N, Sellers WR (2001). Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem 276, 48627-48630.
47. Vazquez F, Matsuoka S, Sellers WR, Yanagida T, Ueda M, Devreotes PN (2006). Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. Proc Natl Acad Sci USA 103, 3633-3638.
48. Vazquez F, Sellers WR (2000). The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 1470, M21-M35.
49. Vogelmann R, Nguyen-Tat MD, Giehl K, Adler G, Wedlic D, Menke A (2005). TGFβ-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN. J Cell Sci 118, 4901-4912.
50. Wojciak-Stothard B, Entwistle A, Garg R, Ridley AJ (1998). Regulation of TNFalpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J Cell Physiol 176, 150-165.